Speakers to Present on New Research on Medical Uses for Psychedelic Drugs, Drug Policy Reform Advocacy, and More
New York, NY –(ENEWSPF)—October 6, 2015. The ninth annual Horizons: Perspectives on Psychedelics conference will be held at the Cooper Union and The New School in New York City on October 10th and 11th.
Horizons focuses on state-of-the-art research into the wide range of applications for psychedelics, providing an invaluable forum for experts and interested others to share ideas and insights, and to rethink the future of these unique substances in science, medicine, culture, and history.
This year, researchers, scholars, and practitioners from the United States, England and Brazil will present new research and insights in neuroscience, end-of-life anxiety, PTSD, substance abuse/addiction, recreational use, public policy, activism, and more.
There are currently significant clinical studies being carried out assessing the different medical uses psilocybin can offer. Researchers at the New York University School of Medicine have been examining the potential of the psychoactive agent to address anxiety and depression associated with cancer through changes in attitudes, awareness and spiritual perceptions of quality of life. Researchers at Johns Hopkins School of Medicine carried out a similar study and have been also looking at spiritual/mystical experiences induced by psilocybin for people interested in smoking cessation. Researchers from both schools will be sharing insights and results from their respective studies.
This year’s presentations include:
“The Voices of the NYU Psilocybin Cancer Anxiety Project”
Stephen Ross, M.D., Associate Professor of Psychiatry and Child & Adolescent Psychiatry at New York University School of Medicine
Jeffrey Guss, M.D., Clinical Assistant Professor of Psychiatry and Child and Adolescent Psychiatry at New York University School of Medicine
Patrick Murphy, B.F.A., Film & Television, New York University Tisch School of the Arts, Casa Vera Productions
“Current Work with Psilocybin in the Treatment of Alcoholism”
Michael P. Bogenschutz, M.D., Professor of Psychiatry, NYU School of Medicine
“Psychedelic Brain Imaging and Depression”
Robin Carhart-Harris, MA, Ph.D., Post-doctoral Research Associate, Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London
“Ayahuasca, Awareness and Depression”
Draulio Barros de Araujo, Ph.D., Professor of Neuroimaging, Brain Institute, Natal, Brazil
“Psilocybin, Meditation, Mystical Experiences, and the Brain”
Frederick Barrett, Ph.D., Faculty Member in Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine
“FDA Approval of MDMA-assisted Psychotherapy: On the Horizon”
Rick Doblin, Ph.D., Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS)
“Psychedelics, Partying, and Policy”
Stefanie Jones, Nightlife Community Engagement Manager, Drug Policy Alliance
“Psychedelics and Death: A Brief Introduction”
Neal M. Goldsmith, Ph.D., Psychotherapist and author, Psychedelic Healing: The Promise of Entheogens for Psychotherapy and Spiritual Development
“Psychedelics and Deep Ecology”
Daniel Pinchbeck, Psychotherapist and author, Author and Co-founder of evolver.net and Reality Sandwich
For a full list of speakers, partners, registration details, and additional information on the conference visit http://horizonsnyc.org